3B Blackbio Dx Limited (NSE:3BBLACKBIO)
1,419.90
-23.40 (-1.62%)
At close: Sep 11, 2026
3B Blackbio Dx Employees
3B Blackbio Dx had 86 employees as of March 31, 2026. The number of employees increased by 1 or 1.18% compared to the previous year.
Employees
86
Change (1Y)
1
Growth (1Y)
1.18%
Revenue / Employee
17.81M INR
Profits / Employee
6.46M INR
Market Cap
12.22B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 86 | 1 | 1.18% |
| Mar 31, 2025 | 85 | 9 | 11.84% |
| Mar 31, 2024 | 76 | 27 | 55.10% |
| Mar 31, 2023 | 49 | 2 | 4.26% |
| Mar 31, 2022 | 47 | 0 | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Biocon | 16,447 |
| Anthem Biosciences | 2,282 |
| Panacea Biotec | 2,149 |
| OneSource Specialty Pharma | 1,674 |
| Concord Biotech | 1,624 |
| Dishman Carbogen Amcis | 1,106 |
| Lyka Labs | 648 |
| Haleos Labs | 592 |